A 28-year-old man with biopsy-proven membranous nephropathy and nephrotic syndrome (proteinuria 6.5 g/day) is being evaluated for the underlying etiology. Serological workup shows negative ANA, negative anti-dsDNA, and normal complement levels. Which investigation is most specific for identifying secondary membranous nephropathy and guiding further management?

Question

Accepted Answer

A. Anti-phospholipase A2 receptor (PLA2R) antibody testing. ## Investigation for Etiology of Membranous Nephropathy

### Clinical Context
This patient has biopsy-confirmed membranous nephropathy with nephrotic syndrome. The negative autoimmune markers (ANA, anti-dsDNA) and normal complement make lupus and other systemic diseases unlikely. The key question is: **primary (idiopathic) vs. secondary membranous nephropathy?**

### Anti-PLA2R Antibody: The Gold Standard for Primary Membranous Nephropathy

**Key Point:** Anti-phospholipase A2 receptor (PLA2R) antibodies are present in 70–80% of patients with primary (idiopathic) membranous nephropathy and are virtually absent in secondary forms.

**High-Yield:** PLA2R is a podocyte antigen that is the major target of autoimmunity in primary membranous nephropathy. Detection of anti-PLA2R antibodies:
- Confirms primary membranous nephropathy
- Excludes secondary causes (malignancy, infection, drugs, autoimmune disease)
- Predicts disease course and response to immunosuppressive therapy
- Helps guide treatment intensity

### Diagnostic Algorithm for Membranous Nephropathy

```mermaid
flowchart TD
  A[Membranous Nephropathy on Biopsy]:::outcome --> B{Clinical & Serological Features}:::decision
  B -->|Negative ANA, anti-dsDNA, normal C3/C4| C[Check Anti-PLA2R]:::action
  C -->|Positive| D[Primary Membranous Nephropathy]:::outcome
  C -->|Negative| E[Consider Secondary Causes]:::action
  B -->|Positive ANA/anti-dsDNA or low complement| F[Lupus Nephritis]:::outcome
  E --> G{Age >60 or Hematuria?}:::decision
  G -->|Yes| H[Screen for Malignancy]:::action
  G -->|No| I[Check HBsAg, HCV Ab]:::action
  H --> J[Chest X-ray, CT abdomen/pelvis]:::action
  I --> K[Serology & Immunofixation]:::action
```

### Comparison: Anti-PLA2R vs. Other Investigations

| Investigation | Utility in Membranous Nephropathy | Sensitivity | Specificity |
|---------------|-----------------------------------|-------------|-------------|
| **Anti-PLA2R** | Confirms primary MN; predicts prognosis | 70–80% | >95% |
| **Immunofixation** | Detects monoclonal protein (secondary MN) | 10–15% | High |
| **HBsAg/HCV Ab** | Identifies viral-associated MN | Variable | High |
| **Chest X-ray** | Screens for occult malignancy | Low | Moderate |
| **ANA/anti-dsDNA** | Excludes lupus | N/A | High |

**Clinical Pearl:** In a young patient (age 28) with negative autoimmune markers and normal complement, anti-PLA2R positivity strongly supports primary membranous nephropathy and makes extensive malignancy screening less urgent. Conversely, anti-PLA2R negativity would warrant investigation for secondary causes (occult malignancy, HBV/HCV, monoclonal protein).

### Management Implications
- **Anti-PLA2R positive:** Immunosuppressive therapy (corticosteroids + cyclophosphamide or calcineurin inhibitors) is indicated
- **Anti-PLA2R negative:** Search for and treat underlying cause (e.g., malignancy, HBV, drug-induced)
- **Serial anti-PLA2R titers:** Declining titers predict remission; rising titers predict relapse

[cite:Robbins 10e Ch 20]

Answer

B. Hepatitis B surface antigen and hepatitis C antibody

Answer

C. Serum and urine immunofixation electrophoresis

Answer

D. Chest X-ray and abdominal ultrasound

Explanation

Investigation for Etiology of Membranous Nephropathy

Clinical Context

Anti-PLA2R Antibody: The Gold Standard for Primary Membranous Nephropathy

Diagnostic Algorithm for Membranous Nephropathy

Comparison: Anti-PLA2R vs. Other Investigations

Management Implications

Practice similar questions

Join our NEET PG community

Investigation	Utility in Membranous Nephropathy	Sensitivity	Specificity
Anti-PLA2R	Confirms primary MN; predicts prognosis	70–80%	>95%
Immunofixation	Detects monoclonal protein (secondary MN)	10–15%	High
HBsAg/HCV Ab	Identifies viral-associated MN	Variable	High
Chest X-ray	Screens for occult malignancy	Low	Moderate
ANA/anti-dsDNA	Excludes lupus	N/A	High